+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostate Cancer"

Prostate Cancer - Competitive landscape, 2024 - Product Thumbnail Image

Prostate Cancer - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
From
Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 1800 Pages
  • Global
From
From
From
From
From
Oncology Ablation Market Report 2024 - Product Thumbnail Image

Oncology Ablation Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Oncology Based in-Vivo CRO Market Report 2025 - Product Thumbnail Image

Oncology Based in-Vivo CRO Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cancer Supportive Care Products Market Report 2024 - Product Thumbnail Image

Cancer Supportive Care Products Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
From
From
From
From
Loading Indicator

Prostate cancer is a type of cancer that affects the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. It is the most common cancer in men in the United States, and the second most common cause of cancer death in men. Prostate cancer is typically treated with surgery, radiation therapy, hormone therapy, chemotherapy, or a combination of these treatments. The prostate cancer market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to benefit from the introduction of novel therapies, such as immunotherapies and targeted therapies, which are expected to improve the prognosis of patients. Additionally, the increasing focus on early diagnosis and the development of new diagnostic tools are expected to drive the market growth. Some of the key players in the prostate cancer market include AstraZeneca, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi. Show Less Read more